Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556554 · ClinicalTrials.gov registry record · NA
Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
A NA study of Diabetes Mellitus, Type I, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT02556554: Completed NA study of Diabetes Mellitus, Type I, sponsored by University of Colorado, Denver.
NCT02556554 is a NA study of Diabetes Mellitus, Type I that has completed, run by University of Colorado, Denver. The registered enrollment target is 67 participants, below the 138-participant average among 5 other Diabetes Mellitus, Type I trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556554, a NA study of Diabetes Mellitus, Type I, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
A single-center, prospective, 'open-label,' investigator-initiated pilot study evaluating the role of continuous glucose monitor (CGM) use either alone or with remote monitoring capabilities during pregnancy associated with T1DM.
Primary Outcome
Glucose variability as measured by glucose excursions from CGM
Conditions Studied
Interventions
- DEVICE Dexcom G4 or G5 Platinum CGM system
- DEVICE Dexcom G4 or G5 Platinum CGM system with Share
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02556554 record still lists
NCT02556554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 138-participant average among 5 other Diabetes Mellitus, Type I trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Diabetes Mellitus, Type I appearing as the primary indexed condition, and to 2 interventions - of which Dexcom G4 or G5 Platinum CGM system is the first listed.
NCT02556554 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02556554 about?
NCT02556554 is a clinical study titled "Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy". A single-center, prospective, 'open-label,' investigator-initiated pilot study evaluating the role of continuous glucose monitor (CGM) use either alone or with remote monitoring capabilities during pregnancy associated with T1DM.
What is the current status of trial NCT02556554?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2015-08. Estimated completion is 2017-08.
What conditions does trial NCT02556554 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type I.
What interventions are being tested in trial NCT02556554?
The interventions under investigation include: Dexcom G4 or G5 Platinum CGM system (DEVICE), Dexcom G4 or G5 Platinum CGM system with Share (DEVICE).
Who is sponsoring clinical trial NCT02556554?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02556554 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type I
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
RECRUITING · NA
-
HLA Demographics Study in Adults With Type 1 Diabetes
RECRUITING
-
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
ACTIVE NOT RECRUITING · Phase 2
-
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
COMPLETED
-
Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia